# 119-s-2760: Reducing Hereditary Cancer Act of 2025

119-s-2760, Reducing Hereditary Cancer Act of 2025, is a 119th Congress bill sponsored by Sen. Murkowski, Lisa [R-AK] (R-AK); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-s-2760
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-2760
- Congress: 119
- Title: Reducing Hereditary Cancer Act of 2025
- Status: introduced
- Introduced: 2025-09-10
- Sponsor: Sen. Murkowski, Lisa [R-AK] (R-AK)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Expands Medicare coverage for hereditary cancer germline mutation testing.** This bill would also require coverage of risk-reducing surgeries and more frequent cancer screenings for people at high inherited risk, all tied to evidence-based oncology guidelines. - People on Medicare with a personal or family history of a hereditary cancer gene mutation or a history suspicious for hereditary cancer would be eligible for germline mutation testing that follows clinical practice guidelines. The bill would allow repeat testing when clinically appropriate. - Individuals found to have a hereditary cancer germline mutation would have Medicare coverage for risk-reducing surgeries that guidelines say are likely to lower cancer risk, and screening frequency limits would be increased to match guideline recommendations, but not less often than annually. Screening examples listed include screening mammography, breast MRI, colonoscopy, and PSA testing. - Coverage decisions would rely on evidence-based guidelines developed by nationally recognized oncology groups such as NCCN, ASCO, or SGO, and Medicare administrative contractors could determine which guideline to apply when multiple guidelines conflict.

## Cosponsors (1)

- Sen. Slotkin, Elissa [D-MI] (D-MI), 2025-09-10T00:00:00.000Z

## Provisions PRIA read

- Medicare coverage for genetic testing: benefit, medium. If enacted, this bill would let Medicare cover germline mutation testing for people with a personal or family history of hereditary cancer. Tests must follow evidence-based clinical guidelines from recognized oncology groups. If guidelines conflict, Medicare contractors would use the least restrict…
- Medicare coverage for risk-reducing surgery: benefit, medium. If enacted, this bill would treat certain risk-reducing surgeries as reasonable and necessary and therefore cover them for people who meet guideline criteria and have a hereditary cancer mutation. The bill would also require the Secretary to increase how often Medicare covers evidence-based screeni…

## Related bills

- 119-s-1541: SHIPS for America Act of 2025
- 119-s-2431: Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026
- 119-s-2120: Older Americans Act Reauthorization Act of 2025
- 119-s-4976: Native Children’s Commission Implementation Act of 2026
- 119-s-1748: Kids Online Safety Act
- 119-s-3492: Essential Caregivers Act of 2025

## Sources
- [119-s-2760 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/2760)

## Related
- [119-s-1541: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-s-1541)
- [119-s-2431: Department of the Interior, Environment, and Related Agencies Appropriations Ac…](https://policyrisk.com/legislation/119-s-2431)
- [119-s-2120: Older Americans Act Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-2120)
- [119-s-4976: Native Children’s Commission Implementation Act of 2026](https://policyrisk.com/legislation/119-s-4976)
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-3492: Essential Caregivers Act of 2025](https://policyrisk.com/legislation/119-s-3492)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-2760 (as of 2026-04-21).